Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Co-Diagnostics Q3 EPS $(0.16) Beats $(0.17) Estimate, Sales $145.380K Miss $150.000K Estimate

Author: Benzinga Newsdesk | November 13, 2025 04:02pm
Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.17) by 8.57 percent. This is a 50 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $145.380 thousand which missed the analyst consensus estimate of $150.000 thousand by 3.08 percent. This is a 77.32 percent decrease over sales of $641.141 thousand the same period last year.

Posted In: CODX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist